Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,865 across all filing types
Latest filing 2024-01-23 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
益丰药房关于向不特定对象发行可转换公司债券申请获得中国证监会核准批文的公告
Capital/Financing Update Classification · 100% confidence The document is an official announcement from the company regarding the approval from the China Securities Regulatory Commission (CSRC) for the company's application to issue convertible bonds to unspecified investors. It includes details about the approval, conditions, and the company's commitment to comply with regulations and disclose information. The document is short (650 characters) and serves as a formal notification of regulatory approval for a financing activity. It does not contain financial statements or detailed financial data but rather an update on capital raising authorization. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2024-01-23 Chinese
益丰药房2024年第一次临时股东大会会议资料
Proxy Solicitation & Information Statement Classification · 95% confidence The document is titled as the "2024 First Extraordinary General Meeting (EGM) Meeting Materials" of Yifeng Pharmacy Chain Co., Ltd. It contains detailed meeting agenda, voting procedures, and two main proposals for shareholder approval: (1) changes to registered capital, business scope, and amendments to the Articles of Association, and (2) amendments to the Independent Director Work System. The content is typical of materials prepared for a shareholders' meeting to inform and guide voting on corporate governance and capital structure matters. It is not a full annual or interim report, audit report, earnings release, or other financial report. It is not a voting results announcement but the meeting materials themselves. The document length is about 15,000 characters, consistent with detailed meeting materials. Therefore, the document fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings such as EGMs or AGMs.
2024-01-19 Chinese
《公司章程》（2024年01月修订）
Governance Information Classification · 100% confidence The document is titled "益丰大药房连锁股份有限公司 公司章程" which translates to "Yifeng Pharmacy Chain Co., Ltd. Articles of Association" or "Company Charter." The content includes detailed chapters on company organization, shareholder rights, board of directors, management, financial accounting, profit distribution, auditing, meeting procedures, and amendments to the articles. It is a comprehensive governance document outlining the internal rules, structure, and governance practices of the company. There is no indication that this is an announcement or a report of financial results, audit, or meeting minutes. It is not a report publication announcement or a regulatory filing. The document is a governance document, specifically the company's articles of association (bylaws). Therefore, the appropriate classification is Governance Information (CGR).
2024-01-12 Chinese
益丰药房关于2024年第一次临时股东大会的通知
AGM Information Classification · 95% confidence The document is a notice about convening the 2024 first extraordinary general meeting of shareholders, detailing the meeting date, voting methods, agenda items, and procedural instructions. It includes an authorization proxy form for shareholders to delegate voting rights. There are no financial statements, earnings data, or detailed management discussions. The document is an announcement of a shareholder meeting, not the meeting materials or results themselves. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings.
2024-01-12 Chinese
益丰药房第四届董事会第三十四次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at a board of directors meeting, including proposals to change registered capital, amend the company's articles of association, and revise the independent director work system. It also announces the scheduling of an extraordinary general meeting to approve these proposals. The document does not contain financial statements or detailed financial data but is a formal disclosure of board decisions and meeting arrangements. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors. The document length is short (1575 characters), and it is not a full report or financial filing but a meeting resolution announcement.
2024-01-12 Chinese
益丰药房关于变更注册资本、增加经营范围及修订《公司章程》的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from Yifeng Pharmacy Chain Co., Ltd. regarding changes to the company's registered capital, expansion of business scope, and amendments to the company's Articles of Association. It details specific changes in share capital, business activities, and governance provisions, including independent director qualifications and committee structures. The document is dated January 13, 2024, and is issued by the company's board of directors. It does not contain financial statements or detailed financial performance data but rather corporate governance and capital structure updates. This type of document fits the category of a Regulatory Filing (RNS) as it is a formal announcement about corporate changes and governance updates without being a full annual or interim report, audit report, or other specific financial filings.
2024-01-12 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.